GRACE Calculator
Free Gracecalculator Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Formula
GRACE Score = Sum of weighted points for age, heart rate, SBP, creatinine, Killip class, cardiac arrest, ST deviation, and cardiac enzymes
Each variable contributes a weighted number of points based on validated ranges. The total score predicts in-hospital and 6-month mortality risk, categorized as Low (108 or below), Intermediate (109-140), or High (above 140).
Worked Examples
Example 1: High-Risk NSTEMI Patient
Problem: A 72-year-old presents with NSTEMI. Heart rate 95 bpm, systolic BP 105 mmHg, creatinine 1.8 mg/dL, Killip class II, no cardiac arrest, ST depression present, troponin elevated.
Solution: Age 72: 75 points\nHeart rate 95: 15 points\nSystolic BP 105: 43 points\nCreatinine 1.8: 13 points\nKillip class II: 20 points\nCardiac arrest: 0 points\nST deviation: 28 points\nElevated enzymes: 14 points\nTotal GRACE Score = 75 + 15 + 43 + 13 + 20 + 0 + 28 + 14 = 208
Result: GRACE Score: 208 | Risk: High | In-hospital mortality: >3% | Early invasive strategy recommended
Example 2: Low-Risk Unstable Angina Patient
Problem: A 48-year-old presents with chest pain. Heart rate 72 bpm, systolic BP 145 mmHg, creatinine 0.9 mg/dL, Killip class I, no cardiac arrest, no ST changes, normal troponin.
Solution: Age 48: 25 points\nHeart rate 72: 3 points\nSystolic BP 145: 24 points\nCreatinine 0.9: 4 points\nKillip class I: 0 points\nCardiac arrest: 0 points\nST deviation: 0 points\nElevated enzymes: 0 points\nTotal GRACE Score = 25 + 3 + 24 + 4 + 0 + 0 + 0 + 0 = 56
Result: GRACE Score: 56 | Risk: Low | In-hospital mortality: <1% | Conservative management appropriate
Frequently Asked Questions
What is the GRACE score and what does it predict?
The GRACE (Global Registry of Acute Coronary Events) score is a validated clinical risk assessment tool used to predict mortality in patients presenting with acute coronary syndromes (ACS), including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina. Developed from data of over 70,000 patients across 14 countries, it estimates both in-hospital mortality and 6-month post-discharge mortality. The score incorporates eight readily available clinical variables: age, heart rate, systolic blood pressure, serum creatinine, Killip class, cardiac arrest at admission, ST-segment deviation, and elevated cardiac biomarkers. It is endorsed by ESC and ACC/AHA guidelines for risk stratification.
How is the GRACE score used in clinical decision-making?
The GRACE score directly influences treatment decisions in acute coronary syndromes by stratifying patients into low, intermediate, and high-risk categories. High-risk patients (GRACE score above 140) are recommended for early invasive strategy with coronary angiography within 24 hours, as they derive the greatest benefit from revascularization. Intermediate-risk patients (scores 109-140) should be considered for invasive management within 72 hours based on additional clinical factors. Low-risk patients (score 108 or below) may be managed conservatively with medical therapy and non-invasive stress testing. The score helps clinicians allocate resources appropriately and guides discussions about prognosis with patients and their families.
What is Killip class and how does it affect the GRACE score?
Killip classification is a clinical assessment system for heart failure severity in the setting of acute myocardial infarction, originally described by Thomas Killip in 1967. Class I indicates no clinical signs of heart failure and carries the best prognosis. Class II shows evidence of mild heart failure with lung crackles in the lower lung fields, an S3 gallop, or elevated jugular venous pressure. Class III represents overt pulmonary edema with crackles in more than half the lung fields. Class IV indicates cardiogenic shock with hypotension and signs of peripheral hypoperfusion. In the GRACE score, increasing Killip class adds substantially more points, with Class IV contributing 59 points compared to zero for Class I.
Why is creatinine included in the GRACE score calculation?
Serum creatinine is included in the GRACE score because renal function is a powerful independent predictor of mortality in acute coronary syndromes. Elevated creatinine reflects impaired renal perfusion, which can result from reduced cardiac output, pre-existing chronic kidney disease, or the cardiorenal syndrome where cardiac and renal dysfunction worsen each other. Patients with elevated creatinine have higher rates of adverse outcomes including death, heart failure, and recurrent ischemic events. Renal impairment also affects medication dosing (particularly anticoagulants and antiplatelet agents), contrast dye use during angiography, and fluid management decisions. The GRACE model assigns progressively higher points as creatinine rises above normal values.
How does age influence the GRACE score and ACS outcomes?
Age is one of the most heavily weighted variables in the GRACE score, reflecting the strong independent association between advancing age and mortality in acute coronary syndromes. Older patients contribute up to 100 points to the total score (for age 90 or above), compared to zero for patients under 30. This weighting reflects multiple biological realities: older patients have more extensive coronary artery disease, more comorbidities, reduced cardiac reserve and physiologic resilience, and higher rates of complications from both the ACS itself and from treatment interventions. Elderly patients also present more frequently with atypical symptoms, leading to delayed diagnosis and treatment. Despite the higher risk, studies show that older patients still benefit from evidence-based therapies including invasive management.
What is the difference between GRACE and TIMI risk scores?
Both GRACE and TIMI scores assess risk in acute coronary syndromes, but they differ significantly in derivation, variables, and discriminatory ability. The GRACE score was derived from a large multinational registry (over 70,000 patients) and uses continuous variables with weighted scoring, providing superior discriminatory power (c-statistic approximately 0.83). The TIMI score was derived from randomized clinical trial data, uses simpler binary variables (7 factors for NSTEMI/UA, different factors for STEMI), and has lower discriminatory ability (c-statistic approximately 0.65). The GRACE score is generally considered more accurate for risk prediction, while the TIMI score is simpler to calculate at the bedside. Current ESC guidelines preferentially recommend the GRACE score for risk stratification in NSTE-ACS.